Dr. Rachel J Kuttichira, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1908 N Grand Ave, Rachel J Kuttichira Md Pc Baldwin Pediatric Care, Baldwin, NY 11510 Phone: 516-377-4120 Fax: 516-377-7746 |
Richard Douglas Lippmann, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 664 Merrick Rd, Baldwin, NY 11510 Phone: 516-771-8123 Fax: 516-208-8343 |
Dr. Robyn A Cadet, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 975 Woodoak Dr, Baldwin, NY 11510 Phone: 516-867-3083 |
Dr. Michael Edward Ronan, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 860 Atlantic Ave, Baldwin, NY 11510 Phone: 516-868-6100 Fax: 516-546-8621 |
Dr. Alan J. Levine, M.D. Pediatrics - Adolescent Medicine Medicare: Medicare Enrolled Practice Location: 860 Atlantic Ave, Baldwin, NY 11510 Phone: 516-868-6100 |
Dr. Reeta Saharia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 865 Merrick Road, Baldwin Medical Plaza #202, Baldwin, NY 11510 Phone: 516-223-9772 Fax: 516-223-3801 |
Dr. Jeffrey Karsdon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 908 Northern Blvd, Baldwin, NY 11510 Phone: 516-223-7915 |
Madhulika Goyal, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2280 Grand Ave, Suite 307, Baldwin, NY 11510 Phone: 516-705-6218 Fax: 516-378-1045 |
Dr. Nirmal Kumar Khurana, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 865 Merrick Rd, Suite 305, Baldwin, NY 11510 Phone: 516-546-6262 Fax: 516-546-5077 |
News Archive
The global obesity epidemic has been escalating for decades, yet long-term prevention efforts have barely begun and are inadequate, according to a new paper from international public health experts published in the August 25, 2011 edition of the journal The Lancet.
Pandemic flu continues to threaten public health, especially in the wake of the recent emergence of an H7N9 low pathogenic avian influenza strain in humans.
Accelerated research findings leading to potentially significant new treatments for fragile X syndrome will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25.
The fight against aging has received a scientific boost thanks to an innovative study done in part by a University of Alberta spin-off company-research that dispels a hard-held belief about the natural ingredient, beta glucan.
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved TWYNSTA®, a new highly effective single pill combination therapy of telmisartan (an angiotensin receptor blocker [ARB]) and amlodipine (a calcium-channel blocker [CCB]). TWYNSTA® is indicated for the treatment of hypertension, alone or with other antihypertensive agents, and as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals.
› Verified 6 days ago